Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study

E Rahme, R Godin, H Nedjar, K Dasgupta… - Thrombosis …, 2021 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) have been proven to be effective
and safe for prevention of ischemic stroke and systemic embolism in patients with non …
被引用次数：7 相关文章

Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study

E Rahme, R Godin, H Nedjar… - Thrombosis …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) have been proven to be effective and safe
for prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial …

Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.

E Rahme, R Godin, H Nedjar, K Dasgupta… - Thrombosis …, 2021 - europepmc.org
Background Direct oral anticoagulants (DOACs) have been proven to be effective and safe
for prevention of ischemic stroke and systemic embolism in patients with non-valvular atrial …

Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study

E Rahme, R Godin, H Nedjar… - Thrombosis …, 2021 - thrombosisresearch.com
Abstract Background Direct oral anticoagulants (DOACs) have been proven to be effective
and safe for prevention of ischemic stroke and systemic embolism in patients with non …

Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study

E Rahme, R Godin, H Nedjar… - Thrombosis …, 2021 - thrombosisresearch.com
Abstract Background Direct oral anticoagulants (DOACs) have been proven to be effective
and safe for prevention of ischemic stroke and systemic embolism in patients with non …